• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed

    2/2/21 5:19:23 PM ET
    $STON
    Get the next $STON alert in real time by email
    SC 13D/A 1 p21-0420sc13da.htm


    SECURITIES AND EXCHANGE COMMISSION
     
    Washington, D.C.  20549  
       
    SCHEDULE 13D/A
     
    Under the Securities Exchange Act of 1934
    (Amendment No. 15)*
     

    StoneMor Inc.

    (Name of Issuer)
     

    Common Stock, par value $0.01 per share

    (Title of Class of Securities)
     

    86184W106

    (CUSIP Number)
     

    Axar Capital Management, LP

    919 Broadway, Suite 502

    New York, NY 10010

    (212) 356-6130

     

    With a copy to:

     

    Stuart D. Freedman, Esq.

    Schulte Roth & Zabel LLP

    919 Third Avenue

    New York, NY 10022

    (212) 756-2000

    (Name, Address and Telephone Number of Person
    Authorized to Receive Notices and Communications)
     

    February 1, 2021

    (Date of Event Which Requires Filing of This Statement)
     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. ý

     

    (Page 1 of 7 Pages)

    ______________________________

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

    CUSIP No. 86184W106

    SCHEDULE 13D/APage 2 of 7 Pages

     

    1

    NAME OF REPORTING PERSON

    Axar Capital Management, LP

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ý

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS

    AF (see Item 3)

    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    7

    SOLE VOTING POWER

    -0-

    8

    SHARED VOTING POWER

    83,110,313

    9

    SOLE DISPOSITIVE POWER

    -0-

    10

    SHARED DISPOSITIVE POWER

    83,110,313

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

    83,110,313

    12

    CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

    See Item 4

    ý
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    70.51%

    14

    TYPE OF REPORTING PERSON

    IA

             

     

     

    CUSIP No. 86184W106

    SCHEDULE 13D/APage 3 of 7 Pages

     

     

    1

    NAME OF REPORTING PERSON

    Axar GP, LLC

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ý

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS

    AF (see Item 3)

    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    7

    SOLE VOTING POWER

    -0-

    8

    SHARED VOTING POWER

    83,110,313

    9

    SOLE DISPOSITIVE POWER

    -0-

    10

    SHARED DISPOSITIVE POWER

    83,110,313

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

    83,110,313

    12

    CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

    See Item 4

    ý
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    70.51%

    14

    TYPE OF REPORTING PERSON

    OO, HC

             

     

     

    CUSIP No. 86184W106

    SCHEDULE 13D/APage 4 of 7 Pages

     

     

    1

    NAME OF REPORTING PERSON

    Andrew Axelrod

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ý

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS

    AF (see Item 3)

    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United States of America

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    7

    SOLE VOTING POWER

    -0-

    8

    SHARED VOTING POWER

    83,110,313

    9

    SOLE DISPOSITIVE POWER

    -0-

    10

    SHARED DISPOSITIVE POWER

    83,110,313

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

    83,110,313

    12

    CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

    See Item 4

    ý
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    70.51%

    14

    TYPE OF REPORTING PERSON

    IN, HC

             

     

     

    CUSIP No. 86184W106

    SCHEDULE 13D/APage 5 of 7 Pages

     

    This Amendment No. 15 ("Amendment No. 15") amends and supplements the statement on Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on March 9, 2018 (the "Original Schedule 13D"), as amended by Amendment No. 1 filed with the SEC on August 1, 2018 ("Amendment No. 1"), Amendment No. 2 filed with the SEC on September 28, 2018 ("Amendment No. 2"), Amendment No. 3 filed with the SEC on October 29, 2018 ("Amendment No. 3"), Amendment No. 4 filed with the SEC on February 5, 2019 ("Amendment No. 4"), Amendment No. 5 filed with the SEC on May 1, 2019 ("Amendment No. 5"), Amendment No. 6 filed with the SEC on June 28, 2019 ("Amendment No. 6"), Amendment No. 7 filed with the SEC on October 29, 2019 ("Amendment No. 7"), Amendment No. 8 filed with the SEC on October 31, 2019 ("Amendment No. 8"), Amendment No. 9 filed with the SEC on January 2, 2020 ("Amendment No. 9"), Amendment No. 10 filed with the SEC on April 3, 2020 ("Amendment No. 10"), Amendment No. 11 filed with the SEC on May 27, 2020 ("Amendment No. 11"), Amendment No. 12 filed with the SEC on June 23, 2020 ("Amendment No. 12"), Amendment No. 13 filed with the SEC on September 8, 2020 ("Amendment No. 13") and Amendment No. 14 filed with the SEC on November 23, 2020 ("Amendment No. 14" and together with the Original Schedule 13D, Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 6, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment 12, Amendment No. 13 and this Amendment No. 15, the "Schedule 13D") with respect to the shares of Common Stock, par value $0.01 per share (the "Common Stock"), of StoneMor Inc., a Delaware corporation (the "Issuer").  Capitalized terms used herein and not otherwise defined in this Amendment No. 15 shall have the meanings set forth in the Schedule 13D.  This Amendment No. 15 amends Items 2(b), 4, 6 and 7 as set forth below.  

     

    Item 2. IDENTITY AND BACKGROUND
       
      Item 2(b) of the Schedule 13D is hereby amended and restated as follows:
       
    (b) The address of the business office of each of the Reporting Persons is 915 Broadway, Suite 502, New York, NY 10010.

     

    Item 4. PURPOSE OF TRANSACTION
       
      Item 4 of the Schedule 13D is hereby amended and supplemented by the addition of the following:
       
      On February 1, 2021, the Investment Manager entered into a Subadvisor Agreement (the “Subadvisor Agreement”) with Cornerstone Trust Management Services LLC (“Cornerstone”), a wholly-owned subsidiary of the Issuer.  Under the terms of the Subadvisor Agreement, The Investment Manager agreed to provide the following services with respect to the assets held in the Issuer's merchandise and perpetual care trust (the "Trusts") and certain pooled investment vehicles administered by the trustee of the Trusts (the "Trustee") in which certain of the Trust's participate or invest (collectively, the "Trust Investment Assets"):  (a) advise Cornerstone with respect to the allocation and investment of the Investment Assets on a non-discretionary basis, including providing advice concerning portfolio allocation among investment strategies; (b) oversee other subcontractors or external managers engaged by Cornerstone to provide advice with respect to the Investment Assets; (c) provide quarterly investment performance reports to and meet on a quarterly basis with the Trust and Compliance Committee of the Board (the "Trust Committee”);

     

    CUSIP No. 86184W106

    SCHEDULE 13D/APage 6 of 7 Pages

     

     

     

    (d) as requested by Cornerstone from time to time, perform the tasks and responsibilities delegated by the Trust Committee to Cornerstone under the Issuer’s investment policy statement; and (e) as requested by Cornerstone, assist Cornerstone in performing its duties by providing general back office and administrative support to Cornerstone and, at Cornerstone’s reasonable request, the Trustee.
       
      Under the Agreement, the Investment Manager will be entitled to a quarterly fee equal to 0.0125% of the value of the Investment Assets through December 31, 2021 and, thereafter, a quarterly fee equal to 0.025% of the value of the Investment Assets.  In each case, the value of the Investment Assets will be determined by the Trustee.  The Agreement also includes customary confidentiality and indemnification provisions.
       
      In connection with the execution of the Agreement, Mr. Axelrod resigned as a member of the Trust Committee.
       
      The initial term of the Subadvisor Agreement is through December 31, 2021 and it automatically renews for an unlimited number of one-year terms thereafter, provided that either party may terminate the Subadvisor Agreement on 90 days’ prior written notice.  
       
      The foregoing description of the Subadvisor Agreement does not purport to be complete and is qualified in its entirety by reference to the full texts of the Subadvisor Agreement, which is attached as Exhibit 23 to this Schedule 13D and is also incorporated herein by reference.

     

    Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER
       
      Item 6 of the Schedule 13D is hereby amended and supplemented by the addition of the following:
       
      The Reporting Persons’ response to Item 4 is incorporated herein by reference.

     

    Item 7. MATERIAL TO BE FILED AS EXHIBITS
       
      Item 7 of the Schedule 13D is hereby amended and supplemented by the addition of the following:
       
    Exhibit 23: Subadvisor Agreement (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K, filed by the Issuer with the Securities and Exchange Commission on February 2, 2021).

     

     

    CUSIP No. 86184W106

    SCHEDULE 13D/APage 7 of 7 Pages

    SIGNATURES

    After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Date: February 2, 2021

     

     

    AXAR CAPITAL Management, LP    
    By: Axar GP, LLC, its General Partner    

     

    By: /s/ Andrew Axelrod

       
    Name: Andrew Axelrod    
    Title: Sole Member    
         
    AXAR GP, LLC    
         
    By: /s/ Andrew Axelrod    
    Name: Andrew Axelrod    
    Title: Sole Member    
         
    /s/ Andrew Axelrod    
    ANDREW AXELROD    
         

     

     

    Get the next $STON alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $STON

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $STON
    SEC Filings

    See more
    • SEC Form 15-12G filed by StoneMor Inc.

      15-12G - Stonemor Inc. (0001753886) (Filer)

      11/14/22 2:46:44 PM ET
      $STON
    • StoneMor Inc. filed SEC Form 8-K: Leadership Update, Completion of Acquisition or Disposition of Assets (Amendment)

      8-K/A - Stonemor Inc. (0001753886) (Filer)

      11/14/22 2:38:15 PM ET
      $STON
    • SEC Form 25-NSE filed by StoneMor Inc.

      25-NSE - Stonemor Inc. (0001753886) (Subject)

      11/4/22 2:07:39 PM ET
      $STON